# A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors

> **NCT02759666** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Neoplasm
- Solid Tumors

## Interventions

- **DRUG:** SHR3162

## Key facts

- **NCT ID:** NCT02759666
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-01
- **Primary completion:** 2019-03-08
- **Final completion:** 2019-04-26
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02759666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02759666, "A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02759666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*